Journal History

2013 The inaugural issue is released, and Vaccines published as a quarterly journal.
2015 Indexed by Scopus (Elsevier), PubMed (NLM) and Emerging Sources Citation Index (ESCI, Web of Science). Full-text papers are archived in the US National Library of Medicine's (NLM) PubMed Central (PMC).
2017 Vaccines launched its first edition of Travel Awards. The journal Twitter account was established.
2018 Indexed by the Science Citation Index Expanded (SCIE – Web of Science) and BIOSIS Previews (Web of Science).
2019 Vaccines received a first Impact Factor of 4.76. The journal ranks 39/158 (Q1) in the 'Immunology' category and 25/136 (Q1) in the "Medicine, Research & Experimental" category.
2020 Vaccines published its 1000th paper.
Vaccines established the following Sections:
Vaccine adjuvants 
Attenuated/Inactivated/Live and Vectored vaccines
Clinical Immunology
Cellular/molecular Immunology
Pathogens-host Immune Interface
Human Papillomavirus Vaccines
Hepatitis Virus Vaccines

Editors-in-Chief

2013–2019 Founding Editor-in-Chief: Prof. Dr. Diane M. Harper
2018– Associate Editor-in-Chief: Prof. Dr. Florian Krammer
2019– Editor-in-Chief: Prof. Dr. Ralph A. Tripp
2020 Section Editor-in-Chief: Dr. Eduardo Gomez-Casado for section “Vaccine Adjuvants”
Section Editor-in-Chief: Prof. Dr. Giampiero Girolomoni for section “Clinical Immunology”
Section Editor-in-Chief: Prof. Dr. Hans-Peter Hartung for section “Cellular/Molecular Immunology”
Section Editor-in-Chief: Dr. Yee-Joo Tan for section “Hepatitis Virus Vaccines”
Section Editor-in-Chief: Prof. Dr. Michael Bukrinsky for section “HIV Vaccines”
Back to TopTop